Gingivectomy or Gingivoplasty — Four or More Contiguous Teeth per Quadrant Template

Gingivectomy/gingivoplasty - four or more contiguous teeth per quadrant.

RMH: Medical history reviewed/updates
Vitals: BP/pulse; other vitals if indicated

Quadrant: Quadrant
Teeth: #Tooth number(s)
Indication: Indication/diagnosis

Consent: Consent/PARQ reviewed; signed/verbally obtained

Periodontal chart/radiographs: Probing/BOP/CAL and radiographs/photos as applicable

Anesthesia: Anesthetic used
Carps: Carpules/amount

Periodontal surgery support: Area/teeth/sites involved and reason procedure is indicated
Pre-op periodontal documentation: Probing, BOP, CAL, recession, furcation, mobility, radiographic bone loss
Surgical access/closure: Flap/access, osseous/soft tissue changes, materials, closure

Procedure:
Bleeding points marked.
Tissue excised with: Tissue excised with
Tissue contoured.
Hemostasis achieved.
Periodontal dressing placed: Periodontal dressing placed

Complications: None or describe.

Patient tolerance: Tolerance/response.

Post-op instructions: Instructions reviewed.
Rx: Prescription or none

NV: Next visit

Documentation requirements

A defensible D4210 note has to prove three things to a reviewer: (1) the diagnosis was a soft-tissue problem, (2) the 4+ contiguous-tooth, per-quadrant threshold was met, and (3) bone was not the target — this was not crown lengthening or osseous surgery in disguise. Site-specific objective findings carry the note; conclusory language ("perio surgery quad UR") does not.

• Medical history and meds — list the offending agent if DIGO is the diagnosis (phenytoin, cyclosporine, tacrolimus, nifedipine, amlodipine, diltiazem). Include anticoagulants, bleeding-disorder history, immunosuppression, diabetes (A1C if known), bisphosphonate / anti-resorptive exposure, and ASA status.
• Vitals — BP and pulse pre-procedure. Required by most state boards for surgical visits and by every sedation-capable practice.
• Quadrant and tooth numbers — the specific contiguous teeth or tooth-bounded spaces being treated, by Universal number. Carriers and most state Medicaid plans require the exact tooth list on the claim and in the chart.
• Indication / diagnosis — name it. "Drug-induced gingival overgrowth secondary to amlodipine, generalized UR quadrant, refractory to non-surgical therapy"; "Chronic inflammatory gingival hyperplasia, pseudopocketing 5–6 mm UR2–UR5, no radiographic bone loss"; "Hereditary gingival fibromatosis, UR quadrant." Generic "gingival enlargement" or "gummy" is a downgrade trigger.
• Pre-op periodontal charting — full 6-point probing depths, BOP, CAL/recession, furcation, mobility, suppuration. The auditor's first question is whether pockets are pseudopockets (gingival origin) or true pockets (attachment loss). The chart has to answer it. Several carriers (Delta Dental, Aetna, multiple state Medicaid plans) require documented probing depths of at least 5 mm in the affected sites for pocket-reduction codes including D4210.
• Radiographs (PA / BW within ~12 months) — the descriptor specifies normal bony configuration. The radiograph proves it. Note diagnostic quality, date, and a one-line interpretation: bone levels at or near CEJ, no horizontal/vertical defects, no furcation involvement. Delta Dental's processing policy explicitly lists PA and BW as the supportive documentation for D4210–D4212.
• Pre-op photographs — strongly recommended for DIGO, esthetic, and hyperplasia cases. They are often the single piece of evidence that converts a denial into a paid appeal.
• Prior non-surgical therapy — most carrier policies expect prior SRP (D4341/D4342) or prophy/D4346 with documented re-evaluation showing the tissue did not respond. State this in the note: "SRP performed [date]; re-eval [date] — generalized fibrotic enlargement persists despite resolved inflammation."
• Consent / PARQ — risks specific to gingivectomy: bleeding, post-op pain, sensitivity, recession, root exposure, recurrence (especially with ongoing DIGO meds), need for adjunctive therapy, alternative of continued non-surgical management.
• Anesthesia — agent, concentration, vasoconstrictor, carpules.
• Surgical detail — bleeding points marked, instrument or modality used (15c blade, Kirkland/Orban knives, electrosurgery, diode/erbium laser), tissue contour created, approximate millimeters of tissue removed where measurable, hemostasis achieved. If a laser is used, name it (e.g., "diode 940 nm, contact mode") — some carriers reimburse identically; some treat laser gingivectomy under the same code, but the chart should still describe the modality.
• Periodontal dressing or none — many practices skip dressing on small fields; if used, name the product (Coe-Pak, Barricaid).
• Complications — none or describe (excess bleeding, syncope, etc.).
• Patient tolerance / response — objective ("tolerated well, hemostasis achieved before dismissal").
• Post-op instructions — written and verbal; soft diet, no rinsing 24 h, chlorhexidine 0.12% if prescribed, return precautions for bleeding/infection.
• Rx — analgesic and/or chlorhexidine when used; "none" with rationale otherwise.
• NV / re-evaluation — most defensible D4210 notes include a 2–4 week post-op check and a longer-interval re-evaluation (often 6–8 weeks) with re-probing to confirm pocket reduction.
• Provider signature and assistant initials.

The note should also make it clear why now: hygiene compromised, hyperplasia progressing despite drug substitution attempt, restorative/ortho prerequisite, etc. "Patient elected surgery" without a clinical trigger is the line that tips a marginal case into denial.

Common denial reasons

D4210 sits in the audit-prone middle of perio: it pays better than non-surgical care, costs the patient more, and the descriptor leaves room for ambiguity. The most common reasons it is denied, downgraded, or recouped:

• Documented pocket depths <5 mm in the surgical sites — the single most common Delta Dental and BCBS denial. Pseudopocket cases need to either show ≥5 mm or lead the narrative with drug-induced etiology and a hygiene/functional rationale.
• No prior non-surgical therapy on file — carrier sees no SRP or D4346 in the lookback window and denies as "non-surgical therapy not exhausted."
• Radiographs show bone loss — when PAs/BWs reveal attachment loss, carriers downgrade D4210 to D4240/D4241 (flap) or D4260/D4261 (osseous), reasoning that the case requires more than soft-tissue treatment.
• Fewer than 4 contiguous teeth or tooth-bounded spaces — claim with only 2–3 teeth in the quadrant denies as miscoded; should have been D4211. Listing the contiguous tooth numbers on the claim is a defense against this.
• Same DOS as same-quadrant SRP — bundled; SRP becomes inclusive to the gingivectomy benefit.
• Same DOS as same-quadrant osseous (D4260) or flap (D4240) — only the more inclusive code pays.
• Cosmetic / esthetic-only documentation — "gummy smile," "patient wants more tooth showing," or "esthetic recontour" without functional justification. Carriers will pay D4210 for symmetry of contour after disease resolution but rarely for elective cosmetic recontouring; aesthetic cases that involve any bone removal must be billed as D4249 anyway.
• Repeat D4210 in the same quadrant within 36 months — flagged as duplicate or as recurrence of previously treated disease without a documented stability period.
• Missing pre-op periodontal charting — full 6-point probing, BOP, CAL is the foundation document. Without it, the carrier has no basis to confirm medical necessity.
• Missing pre-op photos for DIGO / hyperplasia cases — appeal-tier denials almost always require photos when the etiology is hyperplastic.
• No tooth numbers listed — claim doesn't pass the "specific area examined" filter; same flag that hits D0140 hits D4210 for the same reason.
• Unsigned note / missing operator initials — auto-flag in many automated audits.
• D4210 billed as a substitute for D4249 — auditors recognize the pattern when soft-tissue + bone removal occurred and the office reported only D4210; appeal of D4249 denial often forces a rebill, not a switch.

Related templates